Clyde Biosciences

Clyde Biosciences is a contract research organisation based at BioCity Scotland in Newhouse, North Lanarkshire. The company was established following research at the University of Glasgow and trades through Clyde Biosciences Limited (SC418838). Its work focuses on testing how medicines affect the heart.

The business uses human-cell-based assays to examine cardiac electrical activity and contractility during drug research. Its CellOPTIQ platform is designed to measure several signals in the same cells, producing data for pharmaceutical and biotechnology companies assessing potential cardiac effects. This work can contribute to safety and efficacy testing during drug development.

Clyde Biosciences has reported completing hundreds of client studies. Its Scottish laboratory serves research customers beyond the UK, giving the company a role in the wider life sciences supply chain. Study numbers and technical validation claims should be attributed to the company's own current documentation.